Clinical Cancer Research, Vol 3, Issue 10 1837-1840, Copyright © 1997 by American Association for Cancer Research

ARTICLES

Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome

MM Skelly, A Troy, MJ Duffy, HE Mulcahy, C Duggan, TG Connell, DP O'Donoghue and K Sheahan
Departments of Gastroenterology, Nuclear Medicine, and Pathology, St. Vincent's Hospital, Dublin 4, Ireland.

Urokinase-type plasminogen activator (u-PA) is a serine protease that has been implicated in cancer invasion and metastasis. We quantitated u-PA levels in normal colorectal mucosa, adenomatous polyps, and colorectal cancers and correlated these levels with clinicopathological features and patient survival. Detergent extracts were prepared from 133 colorectal cancers, 133 corresponding colorectal mucosal samples, and 15 synchronous adenomatous polyps. u-PA levels were determined using an ELISA, and a cancer:normal u-PA ratio was calculated for each case. u-PA levels were higher in cancers than in normal tissues, whereas adenomas had intermediate levels (P < 0.0001). u-PA levels were unrelated to clinical or pathological features. Survival was decreased in patients with a high cancer:normal u-PA ratio (P = 0.007). Multivariate survival analysis of patients undergoing curative surgery confirmed that the u-PA cancer:normal ratio was related to outcome (relative risk, 2.67; P = 0.02) and was independent of tumor stage (relative risk, 2.26; P = 0.03). Our study suggests that a high ratio of cancer to normal mucosal u-PA indicates an increased risk of colorectal cancer progression. Measurement of u-PA may provide useful prognostic information in patients undergoing curative surgery for colorectal cancer. The aggressive behavior of colorectal cancers with a high u-PA ratio suggests that the protease might be a suitable target for the development of therapeutic agents to prevent invasion and metastasis.

This article has been cited by other articles:

				E A Baker, F G Bergin, and D J Leaper Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression Mol. Pathol., December 1, 2000; 53(6): 307 - 312. [Abstract] [Full Text]

				K. M. Sheehan, K. Sheahan, D. P. O'Donoghue, F. MacSweeney, R. M. Conroy, D. J. Fitzgerald, and F. E. Murray The Relationship Between Cyclooxygenase-2 Expression and Colorectal Cancer JAMA, October 6, 1999; 282(13): 1254 - 1257. [Abstract] [Full Text] [PDF]